4-hydroxy-25-desoxyneorollinicin and cyclic gmp

4-hydroxy-25-desoxyneorollinicin has been researched along with cyclic gmp in 1 studies

Compound Research Comparison

Studies (4-hydroxy-25-desoxyneorollinicin)	Trials (4-hydroxy-25-desoxyneorollinicin)	Recent Studies (post-2010) (4-hydroxy-25-desoxyneorollinicin)	Studies (cyclic gmp)	Trials (cyclic gmp)	Recent Studies (post-2010) (cyclic gmp)
62	0	7	22,346	333	4,062

Protein Interaction Comparison

Protein	Taxonomy	cyclic gmp (IC50)
Phosphodiesterase	Bos taurus (cattle)	0.1
cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens (human)	2.4
cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens (human)	2.4

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chih, TT; Chiu, HF; Hsian, YM; Tseng, CH; Wu, MJ; Wu, YC	1

Other Studies

1 other study(ies) available for 4-hydroxy-25-desoxyneorollinicin and cyclic gmp

Article	Year
Bullatacin, a potent antitumor Annonaceous acetogenin, induces apoptosis through a reduction of intracellular cAMP and cGMP levels in human hepatoma 2.2.15 cells. Biochemical pharmacology, 2003, Feb-01, Volume: 65, Issue:3 Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Colforsin; Cyclic AMP; Cyclic GMP; Drug Interactions; Fluorescein-5-isothiocyanate; Furans; Humans; S-Nitrosoglutathione; Tumor Cells, Cultured	2003

Article

Year

Bullatacin, a potent antitumor Annonaceous acetogenin, induces apoptosis through a reduction of intracellular cAMP and cGMP levels in human hepatoma 2.2.15 cells.

Biochemical pharmacology, 2003, Feb-01, Volume: 65, Issue:3

Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Colforsin; Cyclic AMP; Cyclic GMP; Drug Interactions; Fluorescein-5-isothiocyanate; Furans; Humans; S-Nitrosoglutathione; Tumor Cells, Cultured

2003